BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30338939)

  • 1. Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels.
    Tian Y; Yang T; Yu S; Liu C; He M; Hu C
    J Cell Mol Med; 2018 Dec; 22(12):6327-6337. PubMed ID: 30338939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
    Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
    Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
    Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
    CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways.
    Zeng Z; Leng T; Feng X; Sun H; Inoue K; Zhu L; Xiong ZG
    PLoS One; 2015; 10(3):e0119912. PubMed ID: 25799367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
    Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
    Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells.
    Callera GE; He Y; Yogi A; Montezano AC; Paravicini T; Yao G; Touyz RM
    J Hypertens; 2009 Jan; 27(1):155-66. PubMed ID: 19145781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway.
    Inoue K; Xiong ZG
    Cardiovasc Res; 2009 Aug; 83(3):547-57. PubMed ID: 19454490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation.
    Jiang J; Li MH; Inoue K; Chu XP; Seeds J; Xiong ZG
    Cancer Res; 2007 Nov; 67(22):10929-38. PubMed ID: 18006838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor.
    Du M; Shi F; Zhang H; Xia S; Zhang M; Ma J; Bai X; Zhang L; Wang Y; Cheng S; Yang Q; Leng J
    Oncol Rep; 2015 Aug; 34(2):715-26. PubMed ID: 26058972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).
    Ye Y; Peng L; Vattai A; Deuster E; Kuhn C; Dannecker C; Mahner S; Jeschke U; von Schönfeldt V; Heidegger HH
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2189-2203. PubMed ID: 32488496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Nakashima S; Shiozaki A; Ichikawa D; Hikami S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
    Anticancer Res; 2017 Mar; 37(3):1161-1167. PubMed ID: 28314277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM7 is Involved in the Regulation of Proliferation, Migration and Osteogenic Differentiation of Human Dental Follicle Cells.
    Zuo D; Li J; Huang Y; Li J; Yao S; Xiong L; Zeng J
    Front Biosci (Landmark Ed); 2023 May; 28(5):104. PubMed ID: 37258464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EP1/EP3 receptor agonist 17-pt-PGE
    Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
    Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
    Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
    Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
    Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
    Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
    Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
    Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.